Palladium-catalyzed [4 + 2] cycloaddition of 2-methylidenetrimethylene carbonate or methylene cyclic carbamate with sulfamate-derived cyclic imines-Reference-Cited by-同舟云学术

Palladium-catalyzed [4 + 2] cycloaddition of 2-methylidenetrimethylene carbonate or methylene cyclic carbamate with sulfamate-derived cyclic imines

Published:2023 Issue:40 Volume:21 Page:8107-8111
ISSN:1477-0520
Container-title:Organic & Biomolecular Chemistry
language:en
Short-container-title:Org. Biomol. Chem.

Author:

Sun Li¹,Li Jiyu¹,Wu Yafei¹,Li Ying¹,Chen Junqi¹,Xia Xiaoye¹,Yuan Chunhao²^ORCID,Guo Hongchao³^ORCID,Mao Biming¹^ORCID

Affiliation:

1. School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, Shandong, P. R. China

2. School of Chemistry and Pharmaceutical Engineering, Shandong First Medical University, Shandong Academy of Medical Sciences, Taian 271016, Shandong, P. R. China

3. Department of Applied Chemistry, China Agricultural University, Beijing 100193, China

Abstract

A Pd-catalyzed [4+2] cycloaddition of 2-methylidenetrimethylene carbonate or methylene cyclic carbamate with sulfamate-derived cyclic imines has been successfully developed to afford oxazine or hydropyrimidine derivatives.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/OB/D3OB01361H

Reference34 articles.

1. Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

2. Recent Advances in the Development of Next Generation Non-nucleoside Reverse Transcriptase Inhibitors